11.2 Parasomnias: NREM & REM Sleep Behavior Disorders

11.2 Parasomnias: NREM & REM Sleep Behavior Disorders

Quick Answer: Parasomnias are disruptive sleep disorders involving abnormal movements, behaviors, emotions, and autonomic nervous system activations. NREM Parasomnias (Disorders of Arousal) arise from slow-wave N3 sleep in the first third of the night via state dissociation—the coexistence of motor wakefulness and cortical slow-wave sleep—resulting in confusional arousals, sleepwalking, sleep terrors, and amnesia. In contrast, REM Sleep Behavior Disorder (RBD) occurs in the second half of the night and is characterized by the loss of normal REM skeletal muscle atonia (REM Sleep Without Atonia [RSWA]) due to brainstem dysfunction (sublaterodorsal nucleus / magnocellular reticular formation). Patients act out vivid, action-packed dreams with preserved alertness and dream recall upon awakening. Crucially, idiopathic RBD is a prodromal biomarker for alpha-synucleinopathies (Parkinson's disease, Lewy body dementia, Multiple System Atrophy), and most patients eventually develop one (about 74% within 12 years in a 2019 multicenter study).

Parasomnias represent a captivating yet hazardous interface of neurobiology and behavioral medicine. For the Clinical Sleep Health Specialist (CCSH), recognizing the timing, electroencephalographic correlates, injury risks, and systemic neurological implications of parasomnias is essential for effective patient education and environmental safety coordination.

---

Parasomnia Classification & State Dissociation Theory

Under the International Classification of Sleep Disorders, Third Edition (ICSD-3), parasomnias are categorized based on their sleep-stage of origin into three distinct groups:

1. NREM-Related Parasomnias: Disorders of arousal arising primarily from Stage N3 slow-wave sleep.
2. REM-Related Parasomnias: Conditions characterized by the intrusion of motor activity or distressing mentation during REM sleep (e.g., RBD, Nightmare Disorder, Recurrent Isolated Sleep Paralysis).
3. Other Parasomnias: Conditions not restricted to a single sleep state (e.g., Sleep Enuresis, Exploding Head Syndrome, Sleep-Related Hallucinations).

The Neurobiology of State Dissociation

Classic neurophysiology viewed wakefulness, NREM sleep, and REM sleep as mutually exclusive states. Modern sleep medicine recognizes that sleep-wake state boundaries are regulated by complex neurochemical switches that can experience state dissociation—the simultaneous coexistence of neurophysiologic features from more than one state.

In NREM disorders of arousal, local sleep investigations (depth intracranial EEG and functional neuroimaging) demonstrate that during an event:

• The limbic system, anterior cingulate cortex, brainstem motor networks, and central pattern generators awaken, driving autonomic arousal, locomotion, emotional expression, and eating behaviors.
• The frontoparietal associative cortices, hippocampus, and dorsolateral prefrontal cortex remain synchronized in deep slow-wave delta sleep.

Consequently, the patient exhibits coordinated motor ambulation while remaining cognitively unconscious, inaccessible to rational communication, and completely amnesic for the episode.

---

NREM Disorders of Arousal (Slow-Wave Parasomnias)

NREM disorders of arousal share common physiological features: they typically emerge from Stage N3 slow-wave sleep during the first third of the major sleep period (when N3 pressure is highest), feature a high arousal threshold (patients are difficult to awaken), exhibit marked autonomic activation, and result in complete retrograde amnesia.

1. Confusional Arousals

• Phenomenology: Characterized by mental confusion, blunted emotional affect, slurred speech, and disorientation upon partial arousal from sleep. The patient sits up in bed, looks around blankly, handles bed linens, and resists environmental redirection.
• Absence of Ambulation or Fear: Motor behavior is non-purposeful and confined to the bed. Prominent terror and vocal screaming are absent. Common in infants, toddlers, and individuals suffering from severe sleep inertia.

2. Sleepwalking (Somnambulism)

• Phenomenology: Motor ambulation initiated during N3 sleep. Behaviors range from simple quiet walking to complex, hazardous actions: unlocking doors, navigating stairs, preparing food, rearranging furniture, moving heavy objects, or attempting to drive an automobile.
• Clinical Risks: Falls out of windows, lacerations, wandering outside into freezing temperatures, and head trauma. If awakened forcefully, the patient is disoriented, confused, and may exhibit combative defense responses.

3. Sleep Terrors (Night Terrors / Pavor Nocturnus)

• Phenomenology: Explosive awakening from deep N3 sleep initiated by a blood-curdling scream. The patient sits upright in bed with wide, dilated pupils, exhibiting intense autonomic panic: profound tachycardia, tachypnea, diaphoresis, and flushing.
• Lack of Dream Mentation: The patient appears terrified, stares vacantly, and thrashes violently. They are completely unresponsive to consoling efforts by bed partners or parents. An episode lasts 1 to 10 minutes, after which the patient abruptly returns to deep sleep with total amnesia the following morning.

4. Sleep-Related Eating Disorder (SRED)

• Phenomenology: Recurrent episodes of involuntary compulsive binge eating and drinking during nocturnal arousals from sleep.
• Behavioral Characteristics: Patients consume bizarre, high-caloric combinations (frozen food, butter sticks, salt sandwiches) or toxic, non-ingestible substances (coffee grounds, cleaning solutions, raw meat, cigarette butts). Cooking accidents, burns, lacerations, and dental injuries are common.
• Etiology: Strongly associated with restless legs syndrome (RLS), obstructive sleep apnea, and the use of non-benzodiazepine receptor agonist sedative-hypnotics (zolpidem).

Triggers and Environmental Management of NREM Parasomnias

NREM parasomnias are precipitated by any factor that deepens slow-wave sleep pressure or triggers cortical arousals during N3 sleep:

• Arousal Triggers: Untreated obstructive sleep apnea, periodic limb movements, nocturnal gastroesophageal reflux, environmental noises, alcohol withdrawal, fever, and acute psychological stress.
• Pharmacological Triggers: Zolpidem, zaleplon, lithium, and neuroleptics.
• Environmental Safety Modifications:
  • Installing door and window chime alarms or deadbolts situated out of eye-level reach.
  • Relocating the patient's bedroom to the ground floor.
  • Removing floor clutter, sharp objects, throw rugs, and bedside tables.
  • Locking up firearms, knives, and car keys.
• Behavioral Therapy: Scheduled awakenings—waking the patient 15 to 30 minutes prior to the typical habitual time of the parasomnia episode for 2 to 4 weeks—alters sleep architecture and effectively terminates recurring parasomnias.
• Avoid Physical Restraint: Bed partners and family members must never physically restrain or forcefully shake a sleepwalking or terror-stricken patient, as this escalates violent autonomic agitation and counter-attack reflexes. Instead, gently guide the patient back to bed.

---

REM Sleep Behavior Disorder (RBD): Pathophysiology of REM Without Atonia

REM Sleep Behavior Disorder (RBD) is a REM parasomnia characterized by the dream enactment of vivid, action-packed nightmares accompanied by motor agitation, violent limb flailing, and vocalizations, resulting from the failure of normal REM-related skeletal muscle atonia.

The Brainstem Circuitry of REM Muscle Atonia

Under normal physiological conditions, REM sleep is governed by an active motor inhibition network located in the pontomedullary brainstem:

1. The sublaterodorsal nucleus (SLD) (also known as the locus subcoeruleus in humans) contains glutamatergic "REM-on" neurons.
2. During REM sleep, SLD neurons project descend to inhibitory glycinergic and GABAergic interneurons situated within the ventromedial medulla (magnocellular reticular formation) and spinal cord.
3. These inhibitory premotor interneurons directly hyperpolarize somatic alpha-motor neurons in the anterior horn of the spinal cord, producing complete generalized somatic muscle atonia, sparing only extraocular muscles and the diaphragm.

In RBD, neurodegeneration, vascular lesions, or demyelination damage the SLD, its descending tracts, or the medullary premotor centers. Motor output is released from glycinergic inhibition, producing REM Sleep Without Atonia (RSWA). When central pattern generators fire during REM dream mentation, physical movements break through into the periphery.

Polysomnographic Scoring of RSWA (AASM Rules)

To score RSWA on diagnostic polysomnography, the recording must demonstrate sustained or excessive muscle activity on the submental (chin) and/or anterior tibialis EMG channels during REM sleep:

• Tonic RSWA: An epoch of REM sleep in which $>50\%$ of the duration exhibits chin EMG amplitude greater than the minimum baseline amplitude recorded during NREM sleep.
• Phasic RSWA: Excessive brief bursts of EMG activity ($0.1\text{ to } 5.0\text{ seconds}$ duration) on chin or limb EMG channels, where at least $50\%$ of 3-second mini-epochs contain phasic bursts.

---

RBD: Clinical Presentation & Alpha-Synuclein Phenoconversion

Clinical Presentation

• Dream Enactment: Patients enact aggressive, defensive dreams (being attacked by strangers, chased by predators, defending a spouse). Motor behaviors mirror dream content: punching, kicking, flailing, jumping out of bed, strangling, or screaming obscenities.
• Immediate Alertness & Vivid Recall: When awakened during an event, the patient wakes up immediately, completely alert and coherent, with vivid recall of the accompanying dream scenario. There is no confusion, disorientation, or retrograde amnesia.
• Epidemiology: Predominantly affects males older than 50 years of age ($>80\%$ of cases), though it can occur in younger females, particularly when secondary to narcolepsy or antidepressant use.

The Critical Biomarker for Alpha-Synucleinopathies

Idiopathic RBD is now recognized as one of the most powerful prodromal clinical markers for neurodegenerative alpha-synuclein proteinopathies—diseases characterized by the intracellular accumulation and aggregation of misfolded alpha-synuclein protein:

1. Parkinson's Disease (PD)
2. Dementia with Lewy Bodies (DLB)
3. Multiple System Atrophy (MSA)

Bedroom Safety Modifications & Pharmacotherapy for RBD

• Environmental Safety (Primary Intervention):
  • Placing the mattress directly on the floor or padding the floor with thick tumbling mats.
  • Installing padded bed rails.
  • Moving nightstands, lamps, and sharp furniture far away from the bedside.
  • Removing firearms, knives, and weapons from the bedroom.
  • Advising bed partners to sleep in a separate bed or separate room until motor behaviors are pharmacologically controlled.
• Pharmacotherapy:
  • High-Dose Melatonin ($3\text{ to } 12\text{ mg}$ taken 30–60 minutes before bedtime): Often tried first because of its safety profile; the AASM 2023 RBD guideline conditionally recommends both immediate-release melatonin and clonazepam. Melatonin restores REM muscle atonia through mechanisms in the rostral brainstem and possesses a favorable safety profile with minimal side effects in elderly populations.
  • Clonazepam ($0.5\text{ to } 2.0\text{ mg}$ at bedtime): Highly effective in suppressing violent dream enactment behaviors ($>80\%$ response). However, it carries significant risks in elderly patients, including morning sedation, motor ataxia, falls, cognitive impairment, and exacerbation of untreated obstructive sleep apnea.

Diagnostic Differential: NREM Arousal Disorders vs. RBD vs. Nightmares

Accurately differentiating parasomnias is essential because their prognostic implications, neurological trajectories, and clinical interventions diverge dramatically.